Newsfeeds - Spark Newswire

1 minute read

Calliditas Therapeutics Announces European Medicine Agency’s Committee For Human Medicinal Products Has Decided To ‘continue the assessment of the marketing authorization application (MAA) for Nefecon under standard procedure assessment timelines.’

Today, 9:06 AM

Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") (Nasdaq Stockholm: CALTX) (NASDAQ:CALT), a biopharma company focused on identifying, developing and commercializing novel treatments

CALT

5 minute read

53 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:06 AM

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.

ADGI

3 minute read

38 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 9:06 AM

Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company's platform technology.

ADGI

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 9:06 AM

APOP

7 minute read

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

By Shanthi Rexaline

Today, 9:06 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)

ACAD

3 minute read

26 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 9:06 AM

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday.

ATNX

1 minute read

Calliditas Therapeutics Stock Falls As FDA Pushes Nefecon PDUFA Goal Date To December

By Vandana Singh

Today, 9:06 AM

The FDA has extended the PDUFA goal date for Calliditas Therapeutics AB’s (NASDAQ:CALT) application seeking accelerated approval for Nefecon. Nefecon is an…

CALT

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:06 AM

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.

ACH

1 minute read

FDA
News

Calliditas Therapeutics Announces FDA Has Extended PDUFA Goal Date For Nefecon

By Benzinga Newsdesk

Today, 9:06 AM

Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") (Nasdaq Stockholm: CALTX) (Nasdaq – CALT), a biopharma company focused on identifying, developing and commercializing

CALT

4 minute read

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs

By Shanthi Rexaline

Today, 9:06 AM

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.

ALRN